A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke. Women taking the ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

Symbravo is not substitutable with other formulations of meloxicam or rizatriptan. The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

Headache with the features of migraine without aura usually follows the aura symptoms. Less commonly, headache lacks migrainous features or is completely absent. Previously it was called classic ...

Kids and teens can also get migraines, but Black and Hispanic children seen in emergency rooms are more likely to have their condition go undiagnosed, new research shows. That's concerning ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS ...

HEADACHES increase the odds of suicide, a new study says. While migraines and cluster headaches have already been linked to higher suicide risk, people with milder types, such as tension ...

Hyundai Motor India Limited has updated the Exter and the Aura for the Indian market. As part of the changes, the brand has revised the variant lineup of the models while introducing more features ...